c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
ODTX
Odyssey Therapeutics, Inc. Common Stock
stock
NASDAQ
Market Open
Nov 19, 2026 3:50:04 PM EST
18.44
USD
-2.665%
(-0.51)
331,493
Pre-market
After-hours
15.86
Bid
21.20
Ask
5.34
Spread
Overview
Company
Exchanges
Shorts
News
News
ODTX News
1
/
1
Nov 19, 2026
Day breaks
Nov 10, 2026
10:11 PM EST
FMR LLC Adds 1,059,975 Shares of Odyssey Therapeutics (ODTX) in Q3 2026 Filing
·
GuruFocus
Nov 6, 2026
07:41 AM EST
ODTX Assumed by HC Wainwright & Co. -- Rating Set to Buy
·
GuruFocus
Nov 4, 2026
07:00 AM EST
Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
·
GlobeNewswire Inc.
Oct 20, 2026
03:14 PM EDT
Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript
·
Seeking Alpha
07:00 AM EDT
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
·
GlobeNewswire Inc.
Oct 12, 2026
08:04 AM EDT
Odyssey Therapeutics to present phase 2a trial design for UC
·
Investing.com
03:10 AM EDT
UBS initiates Odyssey Therapeutics stock with buy rating on IBD drug
·
Investing.com
Oct 8, 2026
04:52 PM EDT
Raymond James initiates Odyssey Therapeutics stock coverage with outperform rating
·
Investing.com
Sep 23, 2026
11:38 AM EDT
Odyssey Therapeutics at Stifel forum: pipeline bets and cash runway
·
Investing.com